Astellas Pharma Inc
TSE:4503
Astellas Pharma Inc
Research & Development
Astellas Pharma Inc
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Astellas Pharma Inc
TSE:4503
|
Research & Development
-¥294.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-4%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Research & Development
-¥729.9B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-8%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Research & Development
-¥365.2B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-28%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Research & Development
-¥312.2B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-2%
|
|
S
|
Shionogi & Co Ltd
TSE:4507
|
Research & Development
-¥102.6B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Research & Development
-¥172.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-9%
|
See Also
What is Astellas Pharma Inc's Research & Development?
Research & Development
-294.2B
JPY
Based on the financial report for Mar 31, 2024, Astellas Pharma Inc's Research & Development amounts to -294.2B JPY.
What is Astellas Pharma Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-4%
Over the last year, the Research & Development growth was -7%. The average annual Research & Development growth rates for Astellas Pharma Inc have been -9% over the past three years , -7% over the past five years , and -4% over the past ten years .